Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: an EORTC-GELA Lymphoma Group cohort study.

STUDY QUESTION: How does the successful cryopreservation of semen affect the odds of post-treatment fatherhood among Hodgkin lymphoma (HL) survivors? SUMMARY ANSWER: Among 334 survivors who wanted to have children, the availability of cryopreserved semen doubled the odds of post-treatment fatherhood. WHAT IS KNOWN ALREADY: Cryopreservation of semen is the easiest, safest and most accessible way to safeguard fertility in male patients facing cancer treatment. Little is known about what proportion of patients achieve successful semen cryopreservation. To our knowledge, neither the factors which influence the occurrence of semen cryopreservation nor the rates of fatherhood after semen has been cryopreserved have been analysed before. STUDY DESIGN, SIZE, DURATION: This is a cohort study with nested case-control analyses of consecutive Hodgkin survivors treated between 1974 and 2004 in multi-centre randomized controlled trials. A written questionnaire was developed and sent to 1849 male survivors. PARTICIPANTS/MATERIALS, SETTING, METHODS: Nine hundred and two survivors provided analysable answers. The median age at treatment was 31 years. The median follow-up after cryopreservation was 13 years (range 5-36). MAIN RESULTS AND THE ROLE OF CHANCE: Three hundred and sixty-three out of 902 men (40%) cryopreserved semen before the start of potentially gonadotoxic treatment. The likelihood of semen cryopreservation was influenced by age, treatment period, disease stage, treatment modality and education level. Seventy eight of 363 men (21%) used their cryopreserved semen. Men treated between 1994 and 2004 had significantly lower odds of cryopreserved semen use compared with those treated earlier, whereas alkylating or second-line (chemo)therapy significantly increased the odds of use; no other influencing factors were identified. We found an adjusted odds ratio of 2.03 (95% confidence interval 1.11-3.73, P = 0.02) for post-treatment fatherhood if semen cryopreservation was performed. Forty-eight out of 258 men (19%) who had children after HL treatment became a father using cryopreserved semen. LIMITATIONS, REASONS FOR CAUTION: Data came from questionnaires and so this study potentially suffers from response bias. We could not perform an analysis with correction for duration of follow-up or provide an actuarial use rate due to lack of dates of semen utilization. We do not have detailed information on either the techniques used in cryopreserved semen utilization or the number of cycles needed. STUDY FUNDING/COMPETING INTERESTS: Lance Armstrong Foundation, Dutch Cancer Foundation, René Vogels Stichting, no competing interests.

Impact of primary local treatment on the development of distant metastases or death through locoregional recurrence in young breast cancer patients.

In this study, we tested the hypothesis whether breast conserving therapy (BCT) compared with mastectomy is associated with a negative outcome in terms of distant metastases or death (DMD) and investigated the relation between locoregional recurrence (LRR) and DMD in young breast cancer (BC) patients. This study included a consecutive series of 536 patients ≤40 years of age at diagnosis with pathological T1N0-3M0 BC, treated between 1989 and 2005. A multistate survival model was used to evaluate the influences of local treatment and LRR on DMD, adjusted for potential prognostic factors. Patients were treated with mastectomy (N = 213) or BCT (N = 323). Median age at diagnosis was 36.3 years, with a median follow-up of 9.0 years. The 10-year actuarial cumulative incidence of DMD was 30.6 % after mastectomy and 26.3 % after BCT (P = 0.04). In total, 81 (15 %) LRRs were observed. After BCT, patients had a threefold higher risk of LRR than after mastectomy (HR 2.9; 95 % CI 1.6-5.3). Patients with LRR had a higher risk of DMD compared with patients without LRR (HR 5.5; 95 % CI 2.1-14.5). However, BCT was not negatively associated with DMD-after-LRR (HR 0.47; 95 % CI 0.2-1.1, BCT vs mastectomy). In conclusion, although LRR significantly affected DMD, the increased risk of LRR after BCT compared with mastectomy did not lead to a worse DMD outcome in BC patients ≤40 years of age.

Palliative radiation therapy for AIDS-associated Kaposi's sarcoma by using a single fraction of 800 cGy.

A single radiation fraction of 800 cGy was used in the treatment of acquired immunodeficiency syndrome (AIDS)-associated Kaposi's sarcoma (KS). A total of 74 radiation treatments was given to a total of 31 patients. Of all 74 evaluable treatments, there were 25 objective major responses (6 complete, 19 partial) according to the WHO criteria, while 67 treatments resulted in subjective palliation of the main reason to treat (cosmetic discomfort, pain, or oedema). However, it appeared that the duration of these responses was rather short; in 23 of 36 radiation treatments with a follow-up of more than 4 months, progression of the tumour was seen within that time, while the palliative effect outlasted the survival of the patients in only four cases. It is concluded that a single dose of 800 cGy is an effective treatment for patients with a predicted survival of only a few months, and it should be determined whether a higher fractionated dose improves duration of responses, especially for patients with a good performance.

The HAF enigma: origin and clinical consequences of the appearance of high alkaline fractions on isoelectric focusing patterns of cerebrospinal fluid.

High alkaline fractions (HAF) are irregularly present on isoelectric focusing (IEF) patterns of cerebrospinal fluid (CSF). Therefore, this phenomenon was studied retrospectively in more detail. First, the appearance of HAF in time was recorded and attempts were made to discover a relationship to the biochemical parameters of CSF. No such relationship could be established, nor could any effect of age or sex of the patients or any correlation with ambient temperature or clinical diagnosis be shown. Finally, we have shown conclusively that the cause of this random appearance of HAF can be found in the collodion bags used to concentrate the CSF. This irregular feature of the collodion bags also produces a rise in the frequency of appearance of oligoclonal bands on IEF, probably by blocking the passage of proteins. We conclude that the CSF contains protein material, and that the passage of this through the collodion filters during CSF concentration depends on the regularity of composition of the filters used, occasioning the presence (or absence) of a HAF. Of even greater consequence is the observation that when HAFs do not pass a certain collodion filter, other protein-like material can also be retained, leading to the appearance of oligoclonal bands in IEF, and causing more frequent occurrence of IEF patterns containing oligoclonal bands in CSF. Also, a slight change in the spectrum of oligoclonal bands of CSF has been found when HAFs occur. This indicates that the collodion bags do not retain all protein material in the same way.

Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose.

A retrospective analysis of the incidence of radiation proctitis was performed in 154 patients with carcinoma of the prostate treated with external radiotherapy assisted by CT-scan planning from 1983 to 1985. An attempt was made to assess a dose-response relationship for proctitis. Multivariate Cox regression analysis showed that previous bowel disease or surgery, anterior rectal dose, and average rectal dose contributed to a higher risk of proctitis. The anterior rectal dose was the most important indicator. No statistically significant correlation was found for the posterior rectal dose. The actuarial 2-year incidence of moderate or severe proctitis was 22% for anterior rectal doses less than 70 Gy and 20% for anterior rectal doses between 70 and 75 Gy, but increased to 60% when the dose was more than 75 Gy. A dose effect relation was evident, with a sharp dose-response gradient around 75 Gy at the anterior rectal wall.

Intrathecal Ig synthesis. Its detection by isoelectric focusing and IgG index.

In a retrospective study on 999 patients, the likelihood ratios of the IgG index, Tourtellotte formula and IgG concentration in CSF and in serum, the albumin concentration in CSF and in serum, and the total protein in CSF, were compared in predicting intrathecal Ig synthesis. This synthesis was detected with isoelectric focusing (IEF). No patient was included more than once in the data collection. All patients with high IgG and other abnormalities in serum, as well as all xanthochromic and blood-tinged CSF specimens, were excluded from the study. Construction of ROC curves established that the IgG index, Tourtellotte formula and CSF IgG yield the same information: these parameters indicate the presence of intrathecal IgG synthesis. The likelihood ratio for the IgG index at a cut-off point of 0.80 for a positive test is 20; at a cut-off point of 0.5 for a negative test it is 5. For the Tourtellotte formula, it was found that the likelihood ratio reached a maximal value of 7 at a cut-off value of synthesis of 10 mg/day for a positive test. For a negative result, the formula had a likelihood ratio of 6 at a cut-off value of -5. For CSF IgG, it was found that the likelihood ratio was 4 for a positive test with a cut-off value of 0.1 g/l. For a negative outcome, the determination of CSF IgG is only meaningful at a very low cut-off value (0.03 g/l). The other parameters studied (serum IgG concentration, albumin concentration in CSF and in serum, and total protein in CSF) showed a likelihood ratio equal to 1. It is concluded that only the IgG index, the Tourtellotte formula and the CSF IgG concentration have predictive value for intrathecal Ig synthesis as recorded with IEF.